Filippini T, Malavolti M, Whelton PK, Naska A, Orsini N, Vinceti M. Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies. Circulation. 2021;143:1542–67.
Article PubMed PubMed Central CAS Google Scholar
Gupta DK, Lewis CE, Varady KA, Su YR, Madhur MS, Lackland DT, et al. Effect of dietary sodium on blood pressure: a crossover trial. JAMA. 2023;330:2258–66.
Article PubMed PubMed Central CAS Google Scholar
He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:632–47.
Article PubMed CAS Google Scholar
Ma Y, He FJ, Sun Q, Yuan C, Kieneker LM, Curhan GC, et al. 24-hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med. 2022;386:252–63.
Article PubMed CAS Google Scholar
Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021;385:1067–77.
Article PubMed CAS Google Scholar
Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305:1777–85.
Article PubMed CAS Google Scholar
Mente A, O’Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392:496–506.
Wang JG, Zhang W, Li Y, Liu L. Hypertension in China: epidemiology and treatment initiatives. Nat Rev Cardiol. 2023;20:531–45.
Seidlerová J, Staessen JA, Maillard M, Nawrot T, Zhang H, Bochud M, et al. Association between arterial properties and renal sodium handling in a general population. Hypertension. 2006;48:609–15.
Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension. 2000;36:631–7.
Article PubMed CAS Google Scholar
Zou J, Li Y, Yan CH, Wei FF, Zhang L, Wang JG. Blood pressure in relation to interactions between sodium dietary intake and renal handling. Hypertension. 2013;62:719–25.
Article PubMed CAS Google Scholar
Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron. 1984;37:217–23.
Article PubMed CAS Google Scholar
Koomans HA, Boer WH, Dorhout, Mees EJ. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int. 1989;36:2–12.
Article PubMed CAS Google Scholar
Chen YL, Xu TY, Xu JZ, Zhu LM, Li Y, Wang JG. A speckle tracking echocardiographic study on right ventricular function in primary aldosteronism. J Hypertens. 2020;38:2261–9.
Article PubMed CAS Google Scholar
Chen YL, Xu TY, Xu JZ, Zhu LM, Li Y, Wang JG. A non-invasive left ventricular pressure-strain loop study on myocardial work in primary aldosteronism. Hypertens Res. 2021;44:1462–70.
Article PubMed CAS Google Scholar
Kang YY, Cheng YB, Guo QH, Sheng CS, Huang QF, Xu TY, et al. Renal sodium handling in relation to environmental and genetic factors in untreated Chinese. Am J Hypertens. 2021;34:394–403.
Article PubMed CAS Google Scholar
Sheng Y, Li M, Xu M, Zhang Y, Xu J, Huang Y, et al. Left ventricular and atrial remodelling in hypertensive patients using thresholds from international guidelines and EMINCA data. Eur Heart J Cardiovasc Imaging. 2022;23:166–74.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70.
Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359–66.
Article PubMed CAS Google Scholar
Stevenson PH. Height–weight–surface formula for the estimation of surface area in Chinese subjects. Chin J Physiol. 1937;12:327–30.
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:S19–S40.
Article PubMed CAS Google Scholar
Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–44.
Huang QF, Cheng YB, Guo QH, Liu CY, Kang YY, Sheng CS, et al. Clinic and ambulatory blood pressure in relation to the interaction between plasma advanced glycation end products and sodium dietary intake and renal handling. Hypertens Res. 2022;45:665–74.
Article PubMed CAS Google Scholar
Jin Y, Kuznetsova T, Maillard M, Richart T, Thijs L, Bochud M, et al. Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone. Hypertension. 2009;54:489–95.
Article PubMed CAS Google Scholar
Cwynar M, Gąsowski J, Stompór T, Bartoń H, Wizner B, Dubiel M, et al. Blood pressure and arterial stiffness in patients with high sodium intake in relation to sodium handling and left ventricular diastolic dysfunction status. J Hum Hypertens. 2015;29:583–91.
Article PubMed CAS Google Scholar
Fagard RH, Celis H, Thijs L, Wouters S. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension. 2009;54:1084–91.
Article PubMed CAS Google Scholar
Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, et al. The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. Eur Heart J. 2017;38:3308–17.
Article PubMed CAS Google Scholar
Desai AS, Solomon SD, Shah AM, Claggett BL, Fang JC, Izzo J, et al. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: A randomized clinical trial. JAMA. 2019;322:1077–84.
Article PubMed PubMed Central CAS Google Scholar
Carluccio E, Dini FL, Correale M, Dattilo G, Ciccarelli M, Vannuccini F, et al. Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples. Clin Res Cardiol. 2024;113:856-65.
Natali A, Nesti L, Tricò D, Ferrannini E. Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence. Cardiovasc Diabetol. 2021;20:196.
Article PubMed PubMed Central CAS Google Scholar
Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet. 2020;396:819–29.
Eiskjaer H, Nielsen CB, Pedersen EB. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension. J Intern Med. 1994;236:665–74.
留言 (0)